CG
IDXX icon

Cutler Group’s Idexx Laboratories IDXX Stock Holding History

Cutler Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,400
Closed -$267K – 4480
2018
Q1 		$267K Sell
1,400
-2,400
-63% -$443K 0.02% 669
2017
Q4 		$594K Hold
3,800
– – 0.02% 480
2017
Q3 		$590K Hold
3,800
– – 0.02% 578
2017
Q2 		$613K Buy
3,800
+1,500
+65% +$244K 0.02% 588
2017
Q1 		$355K Buy
+2,300
New +$317K 0.01% 819
2016
Q3 		– Sell
-100
Closed -$9K – 6970
2016
Q2 		$9K Buy
+100
New +$8.59K ﹤0.01% 4267
2016
Q1 		– Sell
-200
Closed -$14K – 6789
2015
Q4 		$14K Buy
+200
New +$14.3K ﹤0.01% 3771

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FEF
Fundsmith Equity Fund Stamford, Connecticut $13.4B AUM
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Cutler Group's IDXX Position: Q2 2018 in Review

Cutler Group sold out of Idexx Laboratories (IDXX) in Q2 2018, closing a stake of 1,400 shares — an estimated $267K sold.

Cutler Group first reported a position in IDXX in Q4 2015 and held it in 7 quarters. The position peaked at $613K in Q2 2017. 665 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

  • Cutler Group reported no remaining Idexx Laboratories position as of Q2 2018 after selling out during the quarter.
  • Cutler Group sold 1,400 Idexx Laboratories shares in Q2 2018, an estimated $267K.
  • Cutler Group first reported a position in Idexx Laboratories in Q4 2015 and held it in 7 quarters.
  • Cutler Group's Idexx Laboratories position peaked at $613K in Q2 2017.
  • 665 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on Cutler Group's 13F filing for Q2 2018, filed 10 Aug 2018.